Not all clients with CLL need therapy. Despite all the latest advances, the iwCLL however recommends watchful observation for patients with asymptomatic illness.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Supplier adalah pe